跳至主要内容
临床试验/NCT01193738
NCT01193738已完成不适用

a Single Blind Cross Over Trial to Compare Osteopathic Compression of Pterygopalatine Node to Placebo Compression in Obstructive Sleep Apnea Syndrome.

Valerie Attali1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10
试验地点
1
主要终点
pharyngeal critical pressure

研究概览

简要总结

The main objective is to evaluate an osteopathic compression of pterygopalatine node on sleep obstructive apnea syndrome (OSA).

详细描述

Osteopathic compression will be compared to a placebo manoeuvre. Efficacy will be assessed by measuring pharyngeal collapsibility

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Male or Female aged 18 years or more
  • •obstructive sleep apnea syndrome with apnea/hypopnea index > or = 15/hour
  • •Body mass Index <40kg/m2

排除标准

  • •pregnant or lactating women
  • •participating to another trial
  • •acute infectious disease of upper respiratory airway tract at inclusion
  • •facial neuralgia at inclusion
  • •patients not able to stop treatment for OSA within one week before each visit
  • •allergy to latex
  • •dental extraction within 15 days before inclusion
  • •pharyngeal surgery in the past
  • •incapable adult

研究组 & 干预措施

active osteopathic compression

Active Comparator

osteopathic compression of Pterygopalatine node

干预措施: osteopathic compression of Pterygopalatine node (Procedure)

placebo osteopathic compression

Placebo Comparator

placebo osteopathic compression

干预措施: osteopathic compression of Pterygopalatine node (Procedure)

结局指标

主要结局

pharyngeal critical pressure

时间窗: 30 minutes after osteopathic compression

The collapsibility of the upper airway will be evaluated by pharyngeal critical pressure,assessed by measuring the intraluminal pressure associated with the cessation of airflow

次要结局

  • pharyngeal critical pressure(48 hours)
  • symptoms(48 hours)
  • adverse events(48 hours)

研究者

发起方
Valerie Attali
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Valerie Attali

MD

Groupe Hospitalier Pitie-Salpetriere

研究点 (1)

Loading locations...

相似试验